Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: A French nationwide study from the Epithor cohort database.
Fiche publication
Date publication
mars 2023
Journal
The Lancet regional health. Europe
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel, Dr PAGES Pierre-Benoit
Tous les auteurs :
Alifano M, Daffré E, Brouchet L, Falcoz PE, Le Pimpec Barthes F, Pages PB, Thomas PA, Dahan M, Porcher R
Lien Pubmed
Résumé
Prognostic assessment in patients undergoing cancer treatments is of paramount importance to plan subsequent management. In resectable lung cancer availability of an easy-to use nomogram to predict long-term outcome would be extremely useful to identify high-risk patients in the era of perioperative targeted and immune therapies.
Mots clés
Lung cancer, Nomogram, Outcome, Surgery, Survival
Référence
Lancet Reg Health Eur. 2023 03;26:100566